MétaCan
Menu
Back to cohort
Record W2029480573 · doi:10.1186/s13058-014-0492-9

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

2014· article· en· W2029480573 on OpenAlexafffund
Karoline Kuchenbaecker, Susan L. Neuhausen, Mark E. Robson, Daniel Barrowdale, Lesley McGuffog, Anna Marie Mulligan, Irene L. Andrulis, Amanda B. Spurdle, Marjanka K. Schmidt, Rita K. Schmutzler, Christoph Engel, Barbara Wappenschmidt, Heli Nevanlinna, Mads Thomassen, Melissa C. Southey, Paolo Radice, Susan J. Ramus, Susan M. Domchek, Katherine L. Nathanson, Andrew Lee, Sue Healey, Robert L. Nussbaum, Timothy R. Rebbeck, Banu Arun, Paul A. James, Beth Y. Karlan, Jenny Lester, Ilana Cass, Breast Cancer Family Registry, Mary Beth Terry, Mary B Daly, David E. Goldgar, Saundra S. Buys, Ramūnas Janavičius, Laima Tihomirova, Nadine Tung, Cecilia M. Dorfling, Elizabeth J. van Rensburg, Linda Steele, Thomas van Overeem Hansen, Bent Ejlertsen, Anne‐Marie Gerdes, Finn C. Nielsen, Joe Dennis, Julie Cunningham, Steven N. Hart, Susan L. Slager, Ana Osório, Javier Benítez, M. Durán, Jeffrey N. Weitzel, Isaac Tafur, Mary Hander, Paolo Peterlongo, Siranoush Manoukian, Bernard Peissel, Gaia Roversi, Giulietta Scuvera, Bernardo Bonanni, P. Mariani, Sara Volorio, Riccardo Dolcetti, Liliana Varesco, Laura Papi, Maria Grazia Tibiletti, Giuseppe Giannini, Florentia Fostira, Irene Konstantopoulou, Judy Garber, Ute Hamann, Alan Donaldson, Carole Brewer, Claire Foo, D. Gareth Evans, Diana Eccles, Fiona Douglas, Angela F. Brady, Jackie Cook, Marc Tischkowitz, Julian Adlard, Julian Barwell, Kai-Ren Ong, Lisa Walker, Louise Izatt, Lucy Side, Michael J. Kennedy, Mark T. Rogers, Mary Porteous, Patrick J. Morrison, Radka Platte, Ros Eeles, Rosemarie Davidson, Shirley Hodgson, Andrew K. Godwin, Kerstin Rhiem, Alfons Meindl, Nina Ditsch, Norbert Arnold, Hansjoerg Plendl, Dieter Niederacher, Christian Sutter, Doris Steinemann, Nadja Bogdanova-Markov, Karin Kast, Raymonda Varon-Mateeva, Shan Wang-Gohrke, Andrea Gehrig, Birgid Markiefka, Bruno Buecher, Cédrick Lefol, Dominique Stoppa-Lyonnet, Étienne Rouleau, Fabienne Prieur, Francesca Damiola, Laure Barjhoux, Laurence Faivre, Michel Longy, Nicolas Sévenet, Olga M. Sinilnikova, Sylvie Mazoyer, Virginie Caux-Moncoutier, Claudine Isaacs, Tom Van Maerken, Kathleen Claes, Marion Piedmonte, Lesley Andrews, John L. Hays, Gustavo C. Rodriguez, Miguel de la Hoya, Sofia Khan, Frans B.L. Hogervorst, Cora M. Aalfs, J. Lange, Hanne Meijers‐Heijboer, Annemarie H. van der Hout, Juul Wijnen, KEP van Roozendaal, Arjen R. Mensenkamp, A M van den Ouweland, Rob B. van der Luijt, Edith Olah, Orland Dı́ez, Conxi Lázaro, Ignacio Blanco, Àlex Teulé, Mireia Menéndez, Anna Jakubowska, Jan Lubiński, Cezary Cybulski, Jacek Gronwald, Katarzyna Jaworska-Bieniek, Katarzyna Durda, Aðalgeir Arason, Christine Maugard, Penny Soucy, Marco Montagna, Simona Agata, Manuel R. Teixeira, Curtis Olswold, Noralane Lindor, V. Shane Pankratz, Emily Hallberg, Xianshu Wang, Csilla I. Szabo, Joseph Vijai, Marina Corines, Anne Lincoln, Andreas Berger, Anneliese Fink-Retter, Christian F. Singer, Christine Rappaport, Daphne Gschwantler Kaulich, Georg Pfeiler, Muy-Kheng Tea, Catherine M. Phelan, Mark H. Greene, Gad Rennert, Evgeny N. Imyanitov, Gord Glendon, Amanda Ewart Toland, Anders Bojesen, Inge Søkilde Pedersen, Uffe Birk Jensen, Maria A. Caligo, Eitan Friedman, Raanan Berger, Yael Laitman, Johanna Rantala, Brita Arver, Niklas Loman, Åke Borg, Hans Ehrencrona, Olufunmilayo I. Olopade, Jacques Simard, Douglas F. Easton, Georgia Chenevix‐Trench, Kenneth Offit, Fergus J. Couch, Antonis C. Antoniou

Bibliographic record

VenueBreast Cancer Research · 2014
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsCancer Care OntarioUniversité LavalCentre hospitalier universitaire de QuébecLunenfeld-Tanenbaum Research InstituteMount Sinai HospitalUniversity of TorontoUniversity Health Network
FundersJonsson Comprehensive Cancer CenterEuropean Regional Development FundMedical Research CouncilCanadian Institutes of Health Researchlékařská fakulta Univerzity KarlovyUniversity of California, San FranciscoNational Institutes of HealthNational Cancer InstituteLiga Portuguesa Contra o CancroMinistero dello Sviluppo EconomicoRadboud Universitair Medisch CentrumDeutsche KrebshilfeUniversitair Medisch Centrum GroningenUniversity of Texas MD Anderson Cancer CenterLeids Universitair Medisch CentrumPerelman School of Medicine, University of PennsylvaniaAssociazione Italiana per la Ricerca sul CancroNational Health and Medical Research CouncilJewish General HospitalKWF KankerbestrijdingState Education Development Agency Republic of LatviaLietuvos Mokslo TarybaIsrael Cancer AssociationOdense UniversitetshospitalOvarian Cancer Research FundLandspítali HáskólasjúkrahúsSusan G. KomenHungarian Scientific Research FundNederlandse Organisatie voor Wetenschappelijk OnderzoekMinistero della SaluteGeneralitat de CatalunyaRussian Foundation for Basic ResearchBeth Israel Deaconess Medical CenterErasmus Medisch CentrumVrije Universiteit AmsterdamNIH Office of the DirectorMinistério da Ciência, Tecnologia e InovaçãoUniversiteit LeidenIstituto Toscano TumoriCancer Association of South AfricaNational Breast Cancer FoundationNational Institute for Health and Care ResearchInstitut Català de la SalutUniversity of PennsylvaniaRadboud UniversiteitFundación Mutua MadrileñaMinistère du Développement Économique, de l’Innovation et de l’ExportationBreast Cancer Research FoundationMcGill UniversityUniverzita Karlova v PrazeClalit Health ServicesDeutsches KrebsforschungszentrumPeter MacCallum Cancer CentreHelsingin ja Uudenmaan SairaanhoitopiiriAmerican Cancer SocietyFonds Wetenschappelijk OnderzoekCancer Center, University of KansasCancerfondenCanadian Breast Cancer Research AllianceEuropean CommissionIstituto Oncologico VenetoRoyal Marsden NHS Foundation TrustHelsingin YliopistoMemorial Sloan-Kettering Cancer CenterGénome QuébecDr. Ralph and Marian Falk Medical Research TrustKansas Bioscience AuthorityEuropean Social FundUniversity of ChicagoInstituto de Salud Carlos IIIOhio State UniversityCancer AustraliaU.S. Department of DefenseCancer Research UKUniversity of Southern California
KeywordsBreast cancerSurgical oncologyMedicineAlleleOncologyMutationBRCA2 ProteinInternal medicineGeneticsCancerGermline mutationBiologyGene

Abstract

fetched live from OpenAlex

INTRODUCTION: More than 70 common alleles are known to be involved in breast cancer (BC) susceptibility, and several exhibit significant heterogeneity in their associations with different BC subtypes. Although there are differences in the association patterns between BRCA1 and BRCA2 mutation carriers and the general population for several loci, no study has comprehensively evaluated the associations of all known BC susceptibility alleles with risk of BC subtypes in BRCA1 and BRCA2 carriers. METHODS: We used data from 15,252 BRCA1 and 8,211 BRCA2 carriers to analyze the associations between approximately 200,000 genetic variants on the iCOGS array and risk of BC subtypes defined by estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and triple-negative- (TN) status; morphologic subtypes; histological grade; and nodal involvement. RESULTS: The estimated BC hazard ratios (HRs) for the 74 known BC alleles in BRCA1 carriers exhibited moderate correlations with the corresponding odds ratios from the general population. However, their associations with ER-positive BC in BRCA1 carriers were more consistent with the ER-positive associations in the general population (intraclass correlation (ICC) = 0.61, 95% confidence interval (CI): 0.45 to 0.74), and the same was true when considering ER-negative associations in both groups (ICC = 0.59, 95% CI: 0.42 to 0.72). Similarly, there was strong correlation between the ER-positive associations for BRCA1 and BRCA2 carriers (ICC = 0.67, 95% CI: 0.52 to 0.78), whereas ER-positive associations in any one of the groups were generally inconsistent with ER-negative associations in any of the others. After stratifying by ER status in mutation carriers, additional significant associations were observed. Several previously unreported variants exhibited associations at P <10(-6) in the analyses by PR status, HER2 status, TN phenotype, morphologic subtypes, histological grade and nodal involvement. CONCLUSIONS: Differences in associations of common BC susceptibility alleles between BRCA1 and BRCA2 carriers and the general population are explained to a large extent by differences in the prevalence of ER-positive and ER-negative tumors. Estimates of the risks associated with these variants based on population-based studies are likely to be applicable to mutation carriers after taking ER status into account, which has implications for risk prediction.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.084
Threshold uncertainty score0.925

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.344
Teacher spread0.324 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations69
Published2014
Admission routes2
Has abstractyes

Explore more

Same venueBreast Cancer ResearchSame topicBRCA gene mutations in cancerFrench-language works237,207